CATALOGO DEI PRODOTTI DELLA RICERCA

RUZZENENTE, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.431
EU - Europa 19.596
AS - Asia 13.420
SA - Sud America 1.785
Continente sconosciuto - Info sul continente non disponibili 583
AF - Africa 533
OC - Oceania 46
Totale 58.394
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.721
RU - Federazione Russa 7.191
SG - Singapore 5.241
IT - Italia 4.239
CN - Cina 3.538
GB - Regno Unito 2.919
BR - Brasile 1.390
HK - Hong Kong 1.169
VN - Vietnam 1.151
DE - Germania 1.086
SE - Svezia 812
IE - Irlanda 783
FR - Francia 736
FI - Finlandia 685
BD - Bangladesh 600
CA - Canada 409
KR - Corea 387
TR - Turchia 357
IN - India 223
NL - Olanda 220
JP - Giappone 163
UA - Ucraina 145
AR - Argentina 137
ES - Italia 136
MX - Messico 134
NG - Nigeria 121
AT - Austria 101
ID - Indonesia 90
IQ - Iraq 90
PL - Polonia 86
ZA - Sudafrica 83
BJ - Benin 77
TG - Togo 74
BE - Belgio 71
EC - Ecuador 63
PK - Pakistan 53
CO - Colombia 48
SA - Arabia Saudita 45
VE - Venezuela 44
CH - Svizzera 43
CZ - Repubblica Ceca 40
LT - Lituania 40
RO - Romania 39
MA - Marocco 36
AU - Australia 35
UZ - Uzbekistan 34
CL - Cile 33
KE - Kenya 32
JM - Giamaica 28
JO - Giordania 26
AE - Emirati Arabi Uniti 25
CR - Costa Rica 25
EG - Egitto 25
PE - Perù 25
MD - Moldavia 24
NP - Nepal 23
BG - Bulgaria 21
MY - Malesia 21
RS - Serbia 21
TN - Tunisia 21
GR - Grecia 20
KZ - Kazakistan 20
PH - Filippine 20
PY - Paraguay 20
DZ - Algeria 18
HN - Honduras 17
NI - Nicaragua 17
BO - Bolivia 15
EE - Estonia 15
GT - Guatemala 15
IR - Iran 15
PT - Portogallo 14
IL - Israele 13
KG - Kirghizistan 13
TH - Thailandia 13
HU - Ungheria 12
LV - Lettonia 12
AL - Albania 11
HR - Croazia 11
TT - Trinidad e Tobago 11
LB - Libano 10
SK - Slovacchia (Repubblica Slovacca) 10
UY - Uruguay 10
AZ - Azerbaigian 9
NZ - Nuova Zelanda 9
OM - Oman 9
DO - Repubblica Dominicana 8
NO - Norvegia 8
PA - Panama 8
PS - Palestinian Territory 8
DK - Danimarca 7
ET - Etiopia 7
LU - Lussemburgo 7
MK - Macedonia 7
SN - Senegal 7
SY - Repubblica araba siriana 7
TW - Taiwan 7
AM - Armenia 6
CI - Costa d'Avorio 6
SV - El Salvador 6
Totale 57.693
Salva come PNG Salva come JPEG
Città #
Dallas 3.203
Ashburn 3.005
Singapore 2.819
Moscow 2.473
San Jose 2.469
Southend 2.142
Chandler 1.472
Hong Kong 1.139
Jacksonville 964
Council Bluffs 912
Verona 894
Dublin 777
Woodbridge 708
Beijing 675
Ann Arbor 529
The Dalles 492
Munich 472
New York 436
Ho Chi Minh City 398
Los Angeles 377
Houston 350
Milan 282
Hanoi 269
Helsinki 250
Jinan 236
Princeton 225
Lawrence 223
Santa Clara 210
Wilmington 210
Rome 199
Buffalo 190
São Paulo 170
Nanjing 165
London 161
Shenyang 150
Tokyo 144
Redondo Beach 132
Turku 117
Orem 115
Columbus 113
Abuja 112
Tianjin 104
Bologna 101
Toronto 100
Hebei 93
Guangzhou 90
Chicago 87
Montréal 87
Sindelfingen 86
Frankfurt am Main 85
Montreal 84
Phoenix 83
Boardman 82
Seattle 80
Zhengzhou 78
Brooklyn 77
Cotonou 77
Changsha 75
Nanchang 75
Lomé 74
Warsaw 74
San Francisco 72
Denver 68
Brussels 67
Haikou 67
Atlanta 66
McKinney 66
Chennai 64
Hangzhou 63
Seoul 62
Washington 62
Amsterdam 61
Johannesburg 60
Nuremberg 60
Ningbo 59
Mexico City 56
Naples 56
Jiaxing 54
Fuzhou 53
Redmond 50
Taizhou 49
Florence 48
Stockholm 48
Boston 47
Lancaster 46
Haiphong 45
Mcallen 45
Padova 45
Manchester 43
Taiyuan 43
Vienna 43
Jakarta 40
Rio de Janeiro 40
Da Nang 36
Kent 36
Lappeenranta 35
Poplar 35
Ankara 34
North Hollywood 34
Redwood City 34
Totale 34.063
Salva come PNG Salva come JPEG
Nome #
Anastomosi Cavo-cavale laterolaterale nel trapianto di fegato, senza by pass venoso e senza shunt porto-cavale temporaneo. Esperienza prospettica del centro trapianti di fegato della Università di Verona. 2.379
Is CT-texture analysis an useful instrument to predict aggressive behaviour of intrahepatic cholangiocarcinoma? 446
'Recurrence of cholangiocarcinoma after surgical treatment: an analysis of modes of occurrence, risk factors, and results of treatment. 344
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 330
[Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal junction]. 278
Assessment of bile and serum mucin5AC in cholangiocarcinoma: Diagnostic performance and biologic significance. 277
A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC) 270
Ablation Difficulty Score: Proposal of a new tool to predict success rate of percutaneous ablation for hepatocarcinoma 270
Array-based genome-wide DNA methylation profiles and gene expression analyses show novel regulatory pathways in alcohol-related hepatocellular carcinoma 269
Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer 260
How much remnant is enough in liver resection? 256
Adjuvant chemotherapy is associated to good survival in patients underwent extended pancreaticoduodenenctomy for pancreatic cancer. 248
Use of Telemedicine for Post-discharge Assessment of the Surgical Wound: International Cohort Study, and Systematic Review with Meta-analysis 244
Adjuvant chemotherapy is associated to good survival in patients underwent extended pancreaticoduodenenctomy for pancreatic cancer. 244
MUC5AC: nuovo marker sierico nel colangiocarcinoma intraepatico e peri-ilare 240
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 236
C-reactive protein as early predictor of complications after minimally invasive colorectal resection 236
DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma 235
Does intrahepatic cholangiocarcinoma have better prognosis compared to perhilar cholangiocarcinoma? 232
Perfusion Changes in Liver Metastases (LM) from Pancreatic Neuroendocrine Tumors (PanNETs) during Everolimus (E) Treatment: Update of Perfusion CT (P-CT) Study 231
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 231
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 230
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 230
Impact of age on short-term outcomes of liver surgery: Lessons learned in 10-years' experience in a tertiary referral hepato-pancreato-biliary center 227
A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size 227
Delaying surgery for patients with a previous SARS-CoV-2 infection 226
Mature CD10+ and immature CD10- neutrophils present in G-CSF-treated donors display opposite effects on T cells 226
Genome-wide DNA methylation and gene expression profiles analysis show novel regulatory pathways in alcohol-related hepatocellular carcinoma 224
Acoustic radiation force impulse (ARFI) imaging in the pre-operative liver function evaluation in patients candidate to liver resection 224
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 224
Treatment of locally advanced rectal cancer in the era of total neoadjuvant therapy: a systematic review and network meta-analysis 223
Essential Trace Elements and Promoter DNA Methylation of Mineral Transporters Genes: Unravelling Novel Epigenetic Mechanisms in Human Hepatocarcinoma. 222
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature 220
Comparison between CT perfusion and indocyanine green retention test: time to peak values can provide a non-invasive esteem of liver function 219
Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. 216
Hepcidin and DNA promoter methylation in hepatocellular carcinoma 216
An Overview of Artificial Intelligence Applications in Liver and Pancreatic Imaging 216
Usefulness of contrast-enhanced intraoperative ultrasonography (CE-IOUS) in patients with colorectal liver metastases after preoperative chemotherapy. 214
Sex differences in oncogenic mutational processes 214
Mesohepatectomy estended to caudate lobe for perihilar cholangiocarcinoma. 210
Prognostic value of portal hypertension after surgical resection of HCC in cirrhotic patients 208
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients 206
Acute hemorrhage secondary to gastric ulcer. Results of emergency endoscopic treatment in 775 cases. 205
Pancreatic resections in patients who refuse blood transfusions. The application of a perioperative protocol for a true bloodless surgery 204
Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment 203
Global DNA methylation and hydroxymethylation differ in hepatocellular carcinoma and cholangiocarcinoma and relate to survival rate 203
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data 203
Epigenetic Regulation Of Hepcidin Expression In Non-Viral Hepatocellular Carcinoma: Results Of A Genome-Wide Study 202
Laparoscopic hepatic resection 200
Patterns and prognostic significance of lymph-node dissection for surgical treatment of peri-hilar and intrahepatic cholangiocarcinoma 199
Role of Combined Ga-68-DOTATOC and F-18-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors Implications for Managing Surgical Decisions 199
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 199
Management of pancreatic trauma: A pancreatic surgeon's point of view 198
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 198
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 197
The Tumor Burden Score: A New "Metro-ticket" Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors 197
DNA Methylation and Hydroxymethylation in Primary Colon Cancer and Synchronous Hepatic Metastasis 197
Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. 195
Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients. 194
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 192
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery 191
The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular carcinoma 191
Contrast-enhanced ultrasonography (CEUS) immediately after percutaneous ablation of hepatocellular carcinoma 190
[US-guided percutaneous management of femoral artery pseudoaneurysms by thrombin injection: personal experience and review of the literature]. 186
Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated? 185
La chirurgia allargata del colangiocarcinoma ilare e intra-epatico 184
A machine learning analysis of difficulty scoring systems for laparoscopic liver surgery 183
Liver resection for multinodular hepatocellular carcinoma. Lesson learn from observational study on 464 patients. 183
Impact of intraoperative blood loss on postoperative morbidity after liver resection for primary and secondary liver cancer 182
La chirurgia allargata del colangiocarcinoma ilare e intra-epatico 182
Prognostication and response assessment in liver and pancreatic tumors: The new imaging 182
Minimally invasive versus open liver resection for nonmetastatic hepatocellular carcinoma staged BCLC - B and - C: an Italian multicentric analysis 181
Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection 181
Influence Of Allogenic Blood Transfusion In Surgical Resection Of HCC. 180
Pancreatic ductal carcinoma: adjuvant chemotherapy after extended pancreaticoduodenenctomy is associated to better survival versus surgery alone. 177
A challenging case of fever of unknown origin (FUO) 176
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study 176
Predicting the complexity of minimally invasive liver resection for hepatocellular carcinoma using machine learning 174
Safety and efficacy of non-steroidal anti-inflammatory drugs to reduce ileus after colorectal surgery 174
[Acute hemorrhage caused by duodenal ulcer. Results of endoscopic treatment of the first bleeding episode and of recurrences] 173
Time-to-Peak Values Can Estimate Hepatic Functional Reserve in Patients Undergoing Surgical Resection: A Comparison Between Perfusion CT and Indocyanine Green Retention Test 173
Laparoscopic colorectal surgery and Enhanced Recovery After Surgery (ERAS) program: Experience with 200 cases from a single Italian center 173
Preoperative assessment of intrahepatic cholangiocarcinoma: CT features with pathological correlation. 172
Caval anastomosis in liver transplantation: prospective experience of Verona liver transplantation program. 172
Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma. 172
Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate 172
Is the liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients. 171
Systematic review of central pancreatectomy and meta-analysis of central versus distal pancreatectomy. 171
Role of Preoperative Biliary Drainage in Jaundiced Patients Who Are Candidates for Pancreatoduodenectomy or Hepatic Resection: Highlights and Drawbacks. 170
Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors? 170
What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes 170
Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis 170
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 169
Il trapianto di fegato a Verona: Esperienza iniziale. 169
Central Pancreatectomy: from Open to Minimally Invasive 169
Primary liver cancer: Prognostic factors and predictive response to therapy 169
Surgical margin, lymph-node status, tumor differentiation, UICC stage and adjuvant therapy are relevant prognostic factors after resection in pancreatic cancer. 168
Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma 168
Advantage of Log Odds of Metastatic Lymph Nodes After Curative-Intent Resection of Gallbladder Cancer 168
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 167
Totale 22.997
Salva come PNG Salva come JPEG
Categoria #
all - tutte 192.188
article - articoli 154.527
book - libri 421
conference - conferenze 30.963
curatela - curatele 419
other - altro 966
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.892
Totale 384.376
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.290 0 0 0 128 94 53 110 124 62 64 167 488
2022/20234.684 280 497 345 761 368 1.121 156 395 464 50 152 95
2023/20243.142 115 253 267 372 345 482 183 238 48 173 399 267
2024/20258.023 417 430 378 1.201 461 362 648 353 1.023 560 704 1.486
2025/202627.356 1.596 1.051 3.112 4.112 6.446 1.751 2.486 1.496 1.994 1.628 722 962
2026/20273.770 418 1.000 1.113 1.239 0 0 0 0 0 0 0 0
Totale 58.394